EOLS
Evolus Inc
Halal Rating :
Last Price
$10.52
Last updated:
Market Cap
-
7D Change
7.35%
1 Year Change
-12.99%
Company Overview
Industries
Exchange
Next Earnings Date
Evolus Inc is a performance beauty company focused on delivering clinical neurotoxin products for aesthetic indications. The company's primary product is Jeuveau®, an injectable treatment for temporary improvement in the appearance of moderate to severe glabellar lines (frown lines between the eyebrows). Evolus markets and sells its products through wholesale channels and directly to physicians.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $61.09m | $81.32m | - | $4.76m | 0.00% | 5.86% |
| June 30, 2024 | $66.91m | $79.31m | - | $4.7m | 0.00% | 5.92% |
| March 31, 2024 | $59.33m | $72.96m | - | $4.7m | 0.00% | 6.44% |
Company Impact
Help us evaluate Evolus Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.